Tolmar Announces Acquisition of JATENZO® (testosterone undecanoate) for the Treatment of Hypogonadism to Expand its Market Leading Urology Portfolio ...Middle East

- Launched in 2020, JATENZO was the first oral softgel testosterone medicine approved in the US by the FDA in more than 60 years - JATENZO is an oral softgel testosterone undecanoate for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence...

Hence then, the article about tolmar announces acquisition of jatenzo testosterone undecanoate for the treatment of hypogonadism to expand its market leading urology portfolio was published today ( Friday 28/10/2022 - 06:32 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Tolmar Announces Acquisition of JATENZO® (testosterone undecanoate) for the Treatment of Hypogonadism to Expand its Market Leading Urology Portfolio )

Also on site :

• Suspect in Mississippi synagogue fire laughed as he confessed to his dad, authorities say
• Fire crews and Hazmat teams responded to fire involving lithium ion batteries at Higuera Street facility
• No injuries reported after partial building collapse in the Bronx, officials say